Correlation Between BiOasis Technologies and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both BiOasis Technologies and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BiOasis Technologies and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between biOasis Technologies and NewAmsterdam Pharma, you can compare the effects of market volatilities on BiOasis Technologies and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BiOasis Technologies with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BiOasis Technologies and NewAmsterdam Pharma.
Diversification Opportunities for BiOasis Technologies and NewAmsterdam Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BiOasis and NewAmsterdam is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding biOasis Technologies and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and BiOasis Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on biOasis Technologies are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of BiOasis Technologies i.e., BiOasis Technologies and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between BiOasis Technologies and NewAmsterdam Pharma
Assuming the 90 days horizon biOasis Technologies is expected to generate 2.89 times more return on investment than NewAmsterdam Pharma. However, BiOasis Technologies is 2.89 times more volatile than NewAmsterdam Pharma. It trades about 0.05 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.1 per unit of risk. If you would invest 12.00 in biOasis Technologies on August 29, 2024 and sell it today you would lose (11.99) from holding biOasis Technologies or give up 99.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
biOasis Technologies vs. NewAmsterdam Pharma
Performance |
| Timeline |
| biOasis Technologies |
| NewAmsterdam Pharma |
BiOasis Technologies and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BiOasis Technologies and NewAmsterdam Pharma
The main advantage of trading using opposite BiOasis Technologies and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BiOasis Technologies position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| BiOasis Technologies vs. Rezolute | BiOasis Technologies vs. Tempest Therapeutics | BiOasis Technologies vs. Forte Biosciences | BiOasis Technologies vs. Dyadic International |
| NewAmsterdam Pharma vs. NewAmsterdam Pharma | NewAmsterdam Pharma vs. Scilex Holding | NewAmsterdam Pharma vs. OmniAb Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |